NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021

NEXT STORY
CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape – Analysis and Forecast, 2021-2031

author_avatar
NASDAQ Market News

MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer

author_avatar
NASDAQ Market News

Adaptimmune Reports First Quarter 2018 Financial Results and Business Update

- Dosing patients in MAGE-A10 lung cancer study at one billion target cell dose ...

author_avatar
NASDAQ Market News